首页 > 最新文献

Journal of Critical Care Medicine最新文献

英文 中文
Non-invasive SpO2/FiO2 ratio (SFR) as surrogate for PaO2/FiO2 ratio (PFR): A scoping review. 无创SpO2/FiO2比值(SFR)替代PaO2/FiO2比值(PFR):范围综述
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0024
Madhura Reddy, Malavika Kulkarni, Sushma Thimmaiah Kanakalakshmi, Laxmi Shenoy, Rama Rani KrishnaBhat

Patient oxygenation significantly impacts clinical outcomes, and continuous monitoring is essential, especially in critical care settings where hypoxia is the leading cause of mortality. PFR (PaO2/FiO2 ratio or P/F ratio) is an invasive method for measuring oxygenation requiring arterial blood gas (ABG) sampling, however it carries complications making non-invasive methods more desirable. SFR (SpO2/FiO2 ratio or S/F ratio), a non-invasive tool based on pulse oximetry, provides a cost-effective and rapid way to monitor oxygenation status, especially in settings where advanced methods are unavailable. A total of 575 articles were screened from databases including Web of Science, Scopus, PubMed, and CINAHL, with 32 articles meeting the inclusion criteria for this scoping review wherein SFR was used as a surrogate for PFR and a diagnostic tool for acute lung injury and ARDS. A total of 81,637 patient records were analyzed, including ABG values, pulse oximetry readings, mechanical ventilator settings, and patient diagnoses. The study population included adults, pediatric patients, and neonates admitted to critical care units, with common diagnoses including acute hypoxemic respiratory failure, ARDS, and COVID-19. In the context of COVID-19, SFR was used to predict the need for mechanical ventilation, with a cut-off of 300 indicating a threshold for imminent ventilation requirement. The studies demonstrated statistically significant sensitivity and specificity for SFR, highlighting its utility as a non-invasive tool for assessing oxygenation status. SFR has shown potential as a reliable non-invasive surrogate for determining oxygenation status across all populations.

患者氧合显著影响临床结果,持续监测是必不可少的,特别是在缺氧是主要死亡原因的重症监护环境中。PFR (PaO2/FiO2比率或P/F比率)是一种需要动脉血气(ABG)采样来测量氧合的侵入性方法,然而它带有并发症,使得非侵入性方法更可取。SFR (SpO2/FiO2比率或S/F比率)是一种基于脉搏血氧仪的无创工具,提供了一种经济高效且快速的监测氧合状态的方法,特别是在无法使用先进方法的情况下。从Web of Science、Scopus、PubMed和CINAHL等数据库中共筛选了575篇文章,其中32篇文章符合本综述的纳入标准,其中SFR被用作PFR的替代指标和急性肺损伤和ARDS的诊断工具。共分析了81637例患者记录,包括血气测定值、脉搏血氧仪读数、机械呼吸机设置和患者诊断。研究人群包括成人、儿科患者和入住重症监护病房的新生儿,常见的诊断包括急性低氧性呼吸衰竭、ARDS和COVID-19。在COVID-19的背景下,SFR用于预测机械通气需求,截断值为300表示即将需要通气的阈值。这些研究表明,SFR的敏感性和特异性具有统计学意义,突出了其作为评估氧合状态的非侵入性工具的实用性。SFR已显示出作为确定所有人群氧合状态的可靠的非侵入性替代指标的潜力。
{"title":"Non-invasive SpO2/FiO2 ratio (SFR) as surrogate for PaO2/FiO2 ratio (PFR): A scoping review.","authors":"Madhura Reddy, Malavika Kulkarni, Sushma Thimmaiah Kanakalakshmi, Laxmi Shenoy, Rama Rani KrishnaBhat","doi":"10.2478/jccm-2025-0024","DOIUrl":"10.2478/jccm-2025-0024","url":null,"abstract":"<p><p>Patient oxygenation significantly impacts clinical outcomes, and continuous monitoring is essential, especially in critical care settings where hypoxia is the leading cause of mortality. PFR (PaO2/FiO2 ratio or P/F ratio) is an invasive method for measuring oxygenation requiring arterial blood gas (ABG) sampling, however it carries complications making non-invasive methods more desirable. SFR (SpO2/FiO2 ratio or S/F ratio), a non-invasive tool based on pulse oximetry, provides a cost-effective and rapid way to monitor oxygenation status, especially in settings where advanced methods are unavailable. A total of 575 articles were screened from databases including Web of Science, Scopus, PubMed, and CINAHL, with 32 articles meeting the inclusion criteria for this scoping review wherein SFR was used as a surrogate for PFR and a diagnostic tool for acute lung injury and ARDS. A total of 81,637 patient records were analyzed, including ABG values, pulse oximetry readings, mechanical ventilator settings, and patient diagnoses. The study population included adults, pediatric patients, and neonates admitted to critical care units, with common diagnoses including acute hypoxemic respiratory failure, ARDS, and COVID-19. In the context of COVID-19, SFR was used to predict the need for mechanical ventilation, with a cut-off of 300 indicating a threshold for imminent ventilation requirement. The studies demonstrated statistically significant sensitivity and specificity for SFR, highlighting its utility as a non-invasive tool for assessing oxygenation status. SFR has shown potential as a reliable non-invasive surrogate for determining oxygenation status across all populations.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"221-232"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing volume status in heart failure: The role of renal duplex ultrasound in evaluating cardiorenal morbidity and heart failure mortality. 评估心力衰竭的容积状态:肾双工超声在评估心肾发病率和心力衰竭死亡率中的作用。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0029
Mohamed Elsayed Elrokh, Waleed Shehata Hassan, Ramadan Ahmed Khalil, Ayman Nehad Moharam, Emad Eldin Omar Abdelaziz

Background: Critical care physicians face challenges managing decompensated heart failure. This study aims to examine the volume status of patients with decompensated heart failure and evaluate the effectiveness of the renal resistive index (RRI) and renal venous flow pattern (VFP) in assessing volume status and predicting outcomes related to cardiorenal syndrome and mortality.

Patients and methods: This prospective study was conducted in the intensive care unit of Kasr Elainy Hospital at Cairo University with patients admitted for acute decompensated heart failure (ADHF). Patients were subjected to clinical screening, laboratory measurements, and echocardiographic examination, including cardiac index renal duplex.

Results: This study included 61 patients with a mean age of 64.8±9.1 years. Renal duplex parameters were 0.692±0.087 for the mean RRI, and the percentages of VFP were as follows: continuous 49.2%, biphasic 27.9%, and monophasic 23%. Elevated proBNP levels and IVC collapsibility index were significantly associated with RRI ≥0.75 and abnormal VFP patterns in assessing volume status. The ROC curve of the RRI, VFP, proBNP, SOFA score, ADHERE risk score, and GWTG-HF score for AKI occurrence showed that RRI has 68% sensitivity to detect AKI, but VFP has better results with 86.4% sensitivity. RRI has a prognostic role in predicting in-hospital mortality in acute heart failure, as RRI has 83.3% sensitivity, and VFP showed better results with 83.3% sensitivity. Also, VFP had a better predictive value for the incidence of 3 months mortality with 90.9% sensitivity, while RRI has 63.4% sensitivity.

Conclusion: Renal duplex measures, such as VFP and RRI, are highly effective prognostic tools for identifying worsening renal function. Beyond renal outcomes, these measures also serve as reliable predictors of mortality and survival in patients with acute decompensated heart failure, offering clinicians the opportunity to tailor therapeutic approaches early during treatment.

背景:重症监护医生面临着管理失代偿性心力衰竭的挑战。本研究旨在研究失代偿性心力衰竭患者的容量状态,并评估肾阻力指数(RRI)和肾静脉血流模式(VFP)在评估容量状态和预测心肾综合征相关结局和死亡率方面的有效性。患者和方法:这项前瞻性研究在开罗大学Kasr Elainy医院重症监护室进行,患者入院为急性失代偿性心力衰竭(ADHF)。患者接受临床筛查、实验室测量和超声心动图检查,包括心脏指数、肾双相。结果:纳入61例患者,平均年龄64.8±9.1岁。肾双相参数平均RRI为0.692±0.087,VFP百分比为:连续49.2%,双相27.9%,单相23%。proBNP水平升高和IVC湿陷性指数升高与RRI≥0.75和VFP异常模式在评估容量状态时显著相关。RRI、VFP、proBNP、SOFA评分、粘附风险评分、GWTG-HF评分对AKI发生的ROC曲线显示,RRI检测AKI的敏感性为68%,而VFP检测AKI的敏感性为86.4%。RRI对预测急性心力衰竭住院死亡率有预后作用,RRI的敏感性为83.3%,VFP的敏感性为83.3%,效果更好。VFP对3个月死亡率的敏感性为90.9%,而RRI的敏感性为63.4%。结论:肾双相测量,如VFP和RRI,是识别肾功能恶化的非常有效的预后工具。除了肾脏预后外,这些指标还可作为急性失代偿性心力衰竭患者死亡率和生存率的可靠预测指标,为临床医生提供了在治疗早期定制治疗方法的机会。
{"title":"Assessing volume status in heart failure: The role of renal duplex ultrasound in evaluating cardiorenal morbidity and heart failure mortality.","authors":"Mohamed Elsayed Elrokh, Waleed Shehata Hassan, Ramadan Ahmed Khalil, Ayman Nehad Moharam, Emad Eldin Omar Abdelaziz","doi":"10.2478/jccm-2025-0029","DOIUrl":"10.2478/jccm-2025-0029","url":null,"abstract":"<p><strong>Background: </strong>Critical care physicians face challenges managing decompensated heart failure. This study aims to examine the volume status of patients with decompensated heart failure and evaluate the effectiveness of the renal resistive index (RRI) and renal venous flow pattern (VFP) in assessing volume status and predicting outcomes related to cardiorenal syndrome and mortality.</p><p><strong>Patients and methods: </strong>This prospective study was conducted in the intensive care unit of Kasr Elainy Hospital at Cairo University with patients admitted for acute decompensated heart failure (ADHF). Patients were subjected to clinical screening, laboratory measurements, and echocardiographic examination, including cardiac index renal duplex.</p><p><strong>Results: </strong>This study included 61 patients with a mean age of 64.8±9.1 years. Renal duplex parameters were 0.692±0.087 for the mean RRI, and the percentages of VFP were as follows: continuous 49.2%, biphasic 27.9%, and monophasic 23%. Elevated proBNP levels and IVC collapsibility index were significantly associated with RRI ≥0.75 and abnormal VFP patterns in assessing volume status. The ROC curve of the RRI, VFP, proBNP, SOFA score, ADHERE risk score, and GWTG-HF score for AKI occurrence showed that RRI has 68% sensitivity to detect AKI, but VFP has better results with 86.4% sensitivity. RRI has a prognostic role in predicting in-hospital mortality in acute heart failure, as RRI has 83.3% sensitivity, and VFP showed better results with 83.3% sensitivity. Also, VFP had a better predictive value for the incidence of 3 months mortality with 90.9% sensitivity, while RRI has 63.4% sensitivity.</p><p><strong>Conclusion: </strong>Renal duplex measures, such as VFP and RRI, are highly effective prognostic tools for identifying worsening renal function. Beyond renal outcomes, these measures also serve as reliable predictors of mortality and survival in patients with acute decompensated heart failure, offering clinicians the opportunity to tailor therapeutic approaches early during treatment.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"275-289"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative assessment of hemodynamic changes and outcomes in ventilator weaning. 呼吸机脱机后血流动力学变化及预后的比较评估。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0022
Dina Zeid Roushdy, Hossam Ahmed Saad, Randa Aly Soliman, Mohammed Aly Shehata, Mohammed Amin Fakhir

Introduction: Mechanical ventilation is fundamental for the management of critically ill patients. The mode of mechanical ventilation may impact the patient in different ways. This study aimed to assess the hemodynamic changes occurring when transitioning between Volume-Controlled Ventilation (VCV) to Variable Pressure Support (VPS) and VCV to Pressure Support (PS) by echocardiography. Also, a comparison between the spontaneous breathing modes in terms of outcomes, specifically, weaning of mechanical ventilation, days on a ventilator, hospital days, and survival, was conducted.

Methods: This prospective observational study was conducted on 40 mechanically ventilated patients who showed readiness for weaning from Mechanical ventilation. When transitioning between VCV and VPS in arm A and from VCV to PS in arm B, an echocardiographic assessment (transesophageal echocardiography and transthoracic echocardiography) was performed. Both modes were further compared in terms of weaning and the success of liberation from mechanical ventilation.

Results: By comparing both arms, there was a significant difference in velocity time integral (VTI) and stroke volume (SV) for TEE and TTE with p-values of 0.044, 0.022, and 0.05, 0.059, respectively. Also, the cardiac output (CO) showed a statistically significant difference between both arms with a p-value of 0.04. On the other side, there was no statistically significant difference between both arms in terms of ventilator days (p-value of 0.88), length of stay (p-value of 0.651), weaning trial success (p-value of 0.525), and survival rate (p-value of 0.525).

Conclusion: The study showed that VPS is a promising modality that can be used in place of PS as a weaning mode. It provides better patient comfort and a more physiological way of breath delivery. The study also concluded that TTE and TEE will show similar results in most patients and that both can be used interchangeably.

机械通气是危重病人救治的基础。机械通气的方式可能以不同的方式影响患者。本研究旨在通过超声心动图评估在容量控制通气(VCV)到可变压力支持(VPS)和VCV到压力支持(PS)之间转换时发生的血流动力学变化。此外,还比较了两种自主呼吸方式的结果,特别是机械通气脱机、使用呼吸机天数、住院天数和生存率。方法:这项前瞻性观察研究对40名机械通气患者进行了研究,这些患者已准备好脱离机械通气。当A组在VCV和VPS之间转换,B组从VCV到PS之间转换时,进行超声心动图评估(经食管超声心动图和经胸超声心动图)。两种模式在脱机和从机械通气中解放成功方面进行了进一步比较。结果:两组比较,TEE组和TTE组的速度时间积分(VTI)和行程体积(SV)的p值分别为0.044、0.022和0.05、0.059,差异均有统计学意义。此外,两组的心输出量(CO)差异有统计学意义,p值为0.04。另一方面,两组患者在呼吸机天数(p值为0.88)、停留时间(p值为0.651)、断奶试验成功率(p值为0.525)和生存率(p值为0.525)方面差异无统计学意义。结论:VPS是一种很有前途的断奶方式,可以代替PS作为断奶方式。它提供了更好的病人舒适度和更生理的呼吸输送方式。该研究还得出结论,在大多数患者中,TTE和TEE将显示相似的结果,两者可以互换使用。
{"title":"Comparative assessment of hemodynamic changes and outcomes in ventilator weaning.","authors":"Dina Zeid Roushdy, Hossam Ahmed Saad, Randa Aly Soliman, Mohammed Aly Shehata, Mohammed Amin Fakhir","doi":"10.2478/jccm-2025-0022","DOIUrl":"10.2478/jccm-2025-0022","url":null,"abstract":"<p><strong>Introduction: </strong>Mechanical ventilation is fundamental for the management of critically ill patients. The mode of mechanical ventilation may impact the patient in different ways. This study aimed to assess the hemodynamic changes occurring when transitioning between Volume-Controlled Ventilation (VCV) to Variable Pressure Support (VPS) and VCV to Pressure Support (PS) by echocardiography. Also, a comparison between the spontaneous breathing modes in terms of outcomes, specifically, weaning of mechanical ventilation, days on a ventilator, hospital days, and survival, was conducted.</p><p><strong>Methods: </strong>This prospective observational study was conducted on 40 mechanically ventilated patients who showed readiness for weaning from Mechanical ventilation. When transitioning between VCV and VPS in arm A and from VCV to PS in arm B, an echocardiographic assessment (transesophageal echocardiography and transthoracic echocardiography) was performed. Both modes were further compared in terms of weaning and the success of liberation from mechanical ventilation.</p><p><strong>Results: </strong>By comparing both arms, there was a significant difference in velocity time integral (VTI) and stroke volume (SV) for TEE and TTE with p-values of 0.044, 0.022, and 0.05, 0.059, respectively. Also, the cardiac output (CO) showed a statistically significant difference between both arms with a p-value of 0.04. On the other side, there was no statistically significant difference between both arms in terms of ventilator days (p-value of 0.88), length of stay (p-value of 0.651), weaning trial success (p-value of 0.525), and survival rate (p-value of 0.525).</p><p><strong>Conclusion: </strong>The study showed that VPS is a promising modality that can be used in place of PS as a weaning mode. It provides better patient comfort and a more physiological way of breath delivery. The study also concluded that TTE and TEE will show similar results in most patients and that both can be used interchangeably.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"265-274"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321258/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nebulized tranexamic acid for hemoptysis in critically and non-critically ill patients: A retrospective analysis. 氨甲环酸雾化治疗危重和非危重患者咯血的回顾性分析。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0031
Nancy Bethuel, Chris Naum, Cynthia Brown

Introduction: Hemoptysis is a commonly encountered diagnosis caused by blood originating from the respiratory tract. Current pharmacological guideline recommendations for treatment do not exist. Tranexamic acid is a synthetic anti-fibrinolytic used in the management of various bleeding complications. Tranexamic acid has gained popularity for the treatment of hemoptysis with limited side effect knowledge. Our aim is to describe the clinical characteristics of patients receiving nebulized tranexamic acid for hemoptysis and compare clinical outcomes to those of patients receiving supportive care.

Materials and methods: This is a retrospective descriptive analysis performed in medical and ICU units at three tertiary hospitals. All patients were hospitalized with hemoptysis between January 1st, 2018 - December 31st, 2021. Demographic information, severity variables, and clinical outcomes were collected from medical records. For statistical analysis, we used t-test for continuous variables, chi-square or fishers' exact test for categorical variables, and propensity analysis to adjust for disease severity and underlying medical conditions.

Results: 488 patients were identified; 96 received tranexamic acid. There were slightly more smokers in the no TXA group (p = 0.04) but otherwise the two groups were similar in terms of demographic characteristics. The average length of hospital and ICU stay, need for mechanical ventilation or bronchoscopy, and mortality were significantly higher in the tranexamic acid group (p<0.01). The propensity analysis showed higher odds of death with nebulized tranexamic acid use, OR 2.51 (1.56-4.02).

Conclusions: There appears to be an indication bias for tranexamic acid based on disease severity without an obvious improvement in clinical outcomes. Our analysis suggests that nebulized tranexamic acid for hemoptysis may be potentially harmful, and further larger prospective research is warranted.

简介:咯血是一种常见的诊断,由血液来自呼吸道。目前尚不存在有关治疗的药理学指南建议。氨甲环酸是一种合成抗纤溶剂,用于治疗各种出血并发症。氨甲环酸已被广泛用于治疗咯血,但对其副作用的了解有限。我们的目的是描述接受雾化氨甲环酸治疗咯血患者的临床特征,并将临床结果与接受支持性治疗的患者进行比较。材料和方法:这是一项回顾性描述性分析,在三家三级医院的内科和ICU病房进行。所有患者均于2018年1月1日至2021年12月31日期间因咯血住院。从医疗记录中收集人口统计信息、严重程度变量和临床结果。对于统计分析,我们对连续变量使用t检验,对分类变量使用卡方或fisher精确检验,并对疾病严重程度和潜在医疗条件进行倾向分析。结果:共发现488例患者;96例接受氨甲环酸治疗。无TXA组吸烟者略多(p = 0.04),但除此之外,两组在人口统计学特征方面相似。氨甲环酸组患者的平均住院时间和ICU住院时间、机械通气或支气管镜检查需求、死亡率均显著高于氨甲环酸组(p)。结论:氨甲环酸根据病情严重程度可能存在指征偏倚,但临床结果没有明显改善。我们的分析表明雾化氨甲环酸治疗咯血可能有潜在的危害,需要进一步进行更大规模的前瞻性研究。
{"title":"Nebulized tranexamic acid for hemoptysis in critically and non-critically ill patients: A retrospective analysis.","authors":"Nancy Bethuel, Chris Naum, Cynthia Brown","doi":"10.2478/jccm-2025-0031","DOIUrl":"10.2478/jccm-2025-0031","url":null,"abstract":"<p><strong>Introduction: </strong>Hemoptysis is a commonly encountered diagnosis caused by blood originating from the respiratory tract. Current pharmacological guideline recommendations for treatment do not exist. Tranexamic acid is a synthetic anti-fibrinolytic used in the management of various bleeding complications. Tranexamic acid has gained popularity for the treatment of hemoptysis with limited side effect knowledge. Our aim is to describe the clinical characteristics of patients receiving nebulized tranexamic acid for hemoptysis and compare clinical outcomes to those of patients receiving supportive care.</p><p><strong>Materials and methods: </strong>This is a retrospective descriptive analysis performed in medical and ICU units at three tertiary hospitals. All patients were hospitalized with hemoptysis between January 1st, 2018 - December 31st, 2021. Demographic information, severity variables, and clinical outcomes were collected from medical records. For statistical analysis, we used t-test for continuous variables, chi-square or fishers' exact test for categorical variables, and propensity analysis to adjust for disease severity and underlying medical conditions.</p><p><strong>Results: </strong>488 patients were identified; 96 received tranexamic acid. There were slightly more smokers in the no TXA group (p = 0.04) but otherwise the two groups were similar in terms of demographic characteristics. The average length of hospital and ICU stay, need for mechanical ventilation or bronchoscopy, and mortality were significantly higher in the tranexamic acid group (p<0.01). The propensity analysis showed higher odds of death with nebulized tranexamic acid use, OR 2.51 (1.56-4.02).</p><p><strong>Conclusions: </strong>There appears to be an indication bias for tranexamic acid based on disease severity without an obvious improvement in clinical outcomes. Our analysis suggests that nebulized tranexamic acid for hemoptysis may be potentially harmful, and further larger prospective research is warranted.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"233-239"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory metabolic acidosis and acute abdominal compartment syndrome following Holmium Laser Enucleation of Prostate (HoLEP). 钬激光前列腺摘除术后难治性代谢性酸中毒和急性腹腔隔室综合征。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0027
Murugananth Nithiyananthan, Shitalkumar Sharad Shah, Aarthi Suhitharan, Suhitharan Thangavelautham

Introduction: Holmium Laser Enucleation of the Prostate (HoLEP) is a widely used minimally invasive surgical technique for benign prostatic hyperplasia (BPH), offering advantages such as reduced bleeding, shorter hospitalization, and elimination of TURP syndrome. However, complications related to fluid absorption and capsular perforation can still occur. We report a rare case of severe refractory metabolic acidosis and acute abdominal compartment syndrome (ACS) following HoLEP.

Case presentation: A 74-year-old male with diabetes and hypertension underwent HoLEP for a 180-ml prostate, during which 106 liters of normal saline irrigation were used over three hours. Intraoperatively, the patient developed sudden respiratory distress and hypotension, with arterial blood gas analysis revealing severe metabolic acidosis (pH 7.141, HCO3 11 mEq/L, Cl 115 mEq/L), primarily due to excessive saline absorption and hyperchloremia. The patient required intubation, vasopressor support, and emergency dialysis due to worsening hemodynamic instability. Postoperative imaging revealed intra-abdominal fluid collection, which was drained percutaneously. After two days of intensive ICU management, the acidosis resolved, and the patient was successfully extubated.

Conclusion: This is the first case highlighting the potential risks of normal saline absorption and the effect of capsular perforation, which caused ACS and refractory acidosis, and required CRRT due to the prolonged duration of HoLEP.

钬激光前列腺去核术(HoLEP)是一种广泛应用于良性前列腺增生(BPH)的微创手术技术,具有减少出血、缩短住院时间和消除TURP综合征等优点。然而,与液体吸收和荚膜穿孔相关的并发症仍然可能发生。我们报告一个罕见的病例严重难治性代谢性酸中毒和急性腹腔隔室综合征(ACS)后,HoLEP。病例介绍:74岁男性糖尿病和高血压行HoLEP检查180毫升前列腺,期间106升生理盐水冲洗超过3小时。术中,患者出现突发性呼吸窘迫和低血压,动脉血气分析显示严重的代谢性酸中毒(pH 7.141, HCO3 11 mEq/L, Cl 115 mEq/L),主要是由于过量的生理盐水吸收和高氯血症。由于血流动力学不稳定恶化,患者需要插管、血管加压支持和紧急透析。术后影像显示腹腔积液,经皮引流。经过两天的ICU强化治疗,酸中毒消退,患者成功拔管。结论:这是第一例强调生理盐水吸收的潜在风险和囊膜穿孔的影响,导致ACS和难治性酸中毒,由于HoLEP持续时间长,需要CRRT。
{"title":"Refractory metabolic acidosis and acute abdominal compartment syndrome following Holmium Laser Enucleation of Prostate (HoLEP).","authors":"Murugananth Nithiyananthan, Shitalkumar Sharad Shah, Aarthi Suhitharan, Suhitharan Thangavelautham","doi":"10.2478/jccm-2025-0027","DOIUrl":"10.2478/jccm-2025-0027","url":null,"abstract":"<p><strong>Introduction: </strong>Holmium Laser Enucleation of the Prostate (HoLEP) is a widely used minimally invasive surgical technique for benign prostatic hyperplasia (BPH), offering advantages such as reduced bleeding, shorter hospitalization, and elimination of TURP syndrome. However, complications related to fluid absorption and capsular perforation can still occur. We report a rare case of severe refractory metabolic acidosis and acute abdominal compartment syndrome (ACS) following HoLEP.</p><p><strong>Case presentation: </strong>A 74-year-old male with diabetes and hypertension underwent HoLEP for a 180-ml prostate, during which 106 liters of normal saline irrigation were used over three hours. Intraoperatively, the patient developed sudden respiratory distress and hypotension, with arterial blood gas analysis revealing severe metabolic acidosis (pH 7.141, HCO<sub>3</sub> 11 mEq/L, Cl 115 mEq/L), primarily due to excessive saline absorption and hyperchloremia. The patient required intubation, vasopressor support, and emergency dialysis due to worsening hemodynamic instability. Postoperative imaging revealed intra-abdominal fluid collection, which was drained percutaneously. After two days of intensive ICU management, the acidosis resolved, and the patient was successfully extubated.</p><p><strong>Conclusion: </strong>This is the first case highlighting the potential risks of normal saline absorption and the effect of capsular perforation, which caused ACS and refractory acidosis, and required CRRT due to the prolonged duration of HoLEP.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"301-306"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321252/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angioedema: Is ICU admission warranted? A single institution assessment. 血管性水肿:是否需要住院?单一机构评估。
IF 1.7 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-07-31 eCollection Date: 2025-07-01 DOI: 10.2478/jccm-2025-0023
Madeleine Brill-Edwards, W Chase Hamilton, Erika J Yoo, Jennifer Costello, George J Koenig, Murray J Cohen, Joshua A Marks

Introduction: Angioedema has potential for rapid airway decompensation requiring intervention. Patients are often admitted to an ICU for "airway watch." There is a lack of evidence to support which patients require this.

Aim: We aimed to characterize admission patterns and outcomes of angioedema patients at our institution to assess resource utilization and necessity of ICU use. We hypothesized that patients not requiring intubation upon presentation are safe to manage outside the ICU.

Materials and methods: Retrospective chart review of patients admitted to our urban academic quaternary referral institution with angioedema ICD-10 codes between 2017 and 2020. Charts reviewed for demographics, etiology, admission location, level of care, length of stay (LOS), intubation information, discharge destination, and specific treatment administered. Statistical analysis included a t-test for continuous variables (LOS).

Results: Of 135 encounters for angioedema, 117 patients were admitted. 50 were admitted to an ICU. Patients were evenly split based on sex, majority black, and the most common etiology was ACE-inhibitor use. 20 required airway intervention with intubations primarily outside the ICU setting and only 2 in the ICU. 1 surgical airway performed in the ED. The mean time from presentation to intubation was 2.7 hours (Min 0h; Max 7.5h). The average ICU LOS for non-intubated patients was 1.1 days, with hospital LOS 1.5 days compared to 0.25 days for those not admitted to an ICU (p<0.001). For intubated patients, average ICU LOS was 4.3 days, with hospital LOS 6.2 days. All intubated patients were successfully liberated from the ventilator. No deaths occurred.

Conclusion: Most angioedema encounters did not require airway intervention within the first hours of presentation. Airway decompensation and intervention mostly occurred prior to the ICU setting. ICU resources should be carefully allocated and may be unnecessary for patients presenting with angioedema who are not intubated on initial evaluation.

血管性水肿有可能导致气道快速失代偿,需要干预。患者通常被送进ICU进行“气道监护”。缺乏证据支持哪些患者需要这种治疗。目的:我们旨在描述我院血管性水肿患者的入院模式和预后,以评估资源利用和ICU使用的必要性。我们假设患者在就诊时不需要插管,在ICU外治疗是安全的。材料与方法:回顾性分析2017 - 2020年在我市学术性四级转诊机构就诊的血管性水肿ICD-10编码患者。图表回顾了人口统计学、病因学、入院地点、护理水平、住院时间(LOS)、插管信息、出院目的地和特定治疗。统计分析包括连续变量(LOS)的t检验。结果:135例血管性水肿患者中,117例住院。50人住进重症监护室。患者按性别平均分布,大多数为黑人,最常见的病因是ace抑制剂的使用。20例主要在ICU外需要插管进行气道干预,只有2例在ICU内。在急诊科进行了1例气管插管手术。从出现到插管平均时间为2.7小时(最小0小时;最大7.5小时)。非插管患者在ICU的平均生存时间为1.1天,在医院的平均生存时间为1.5天,而非住院患者的平均生存时间为0.25天(结论:大多数血管性水肿患者在出现的最初几个小时内不需要气道干预。气道失代偿和干预大多发生在ICU设置之前。ICU资源应谨慎分配,对于在初始评估时未插管的血管性水肿患者可能是不必要的。
{"title":"Angioedema: Is ICU admission warranted? A single institution assessment.","authors":"Madeleine Brill-Edwards, W Chase Hamilton, Erika J Yoo, Jennifer Costello, George J Koenig, Murray J Cohen, Joshua A Marks","doi":"10.2478/jccm-2025-0023","DOIUrl":"10.2478/jccm-2025-0023","url":null,"abstract":"<p><strong>Introduction: </strong>Angioedema has potential for rapid airway decompensation requiring intervention. Patients are often admitted to an ICU for \"airway watch.\" There is a lack of evidence to support which patients require this.</p><p><strong>Aim: </strong>We aimed to characterize admission patterns and outcomes of angioedema patients at our institution to assess resource utilization and necessity of ICU use. We hypothesized that patients not requiring intubation upon presentation are safe to manage outside the ICU.</p><p><strong>Materials and methods: </strong>Retrospective chart review of patients admitted to our urban academic quaternary referral institution with angioedema ICD-10 codes between 2017 and 2020. Charts reviewed for demographics, etiology, admission location, level of care, length of stay (LOS), intubation information, discharge destination, and specific treatment administered. Statistical analysis included a t-test for continuous variables (LOS).</p><p><strong>Results: </strong>Of 135 encounters for angioedema, 117 patients were admitted. 50 were admitted to an ICU. Patients were evenly split based on sex, majority black, and the most common etiology was ACE-inhibitor use. 20 required airway intervention with intubations primarily outside the ICU setting and only 2 in the ICU. 1 surgical airway performed in the ED. The mean time from presentation to intubation was 2.7 hours (Min 0h; Max 7.5h). The average ICU LOS for non-intubated patients was 1.1 days, with hospital LOS 1.5 days compared to 0.25 days for those not admitted to an ICU (p<0.001). For intubated patients, average ICU LOS was 4.3 days, with hospital LOS 6.2 days. All intubated patients were successfully liberated from the ventilator. No deaths occurred.</p><p><strong>Conclusion: </strong>Most angioedema encounters did not require airway intervention within the first hours of presentation. Airway decompensation and intervention mostly occurred prior to the ICU setting. ICU resources should be carefully allocated and may be unnecessary for patients presenting with angioedema who are not intubated on initial evaluation.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 3","pages":"240-246"},"PeriodicalIF":1.7,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The challenge of antimicrobial resistance in intensive care setting. 重症监护环境中抗菌素耐药性的挑战。
IF 0.9 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-04-30 eCollection Date: 2025-04-01 DOI: 10.2478/jccm-2025-0020
Prisco Piscitelli, Vincenzo Costigliola, Leonard Azamfirei
{"title":"The challenge of antimicrobial resistance in intensive care setting.","authors":"Prisco Piscitelli, Vincenzo Costigliola, Leonard Azamfirei","doi":"10.2478/jccm-2025-0020","DOIUrl":"10.2478/jccm-2025-0020","url":null,"abstract":"","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 2","pages":"109-111"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of antiseizure medication on mortality in spontaneous aneurysmal subarachnoid hemorrhage. 抗癫痫药物对自发性动脉瘤性蛛网膜下腔出血患者死亡率的影响。
IF 0.9 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-04-30 eCollection Date: 2025-04-01 DOI: 10.2478/jccm-2025-0014
John Harold Kanter, Adam C Glaser, Pablo Martinez-Camblor, Jakob V E Gerstl, Anna B Lebouille-Veldman, Harshit Arora, Lauren Buhl, Myles D Boone, Christopher S Ogilvy

Background: Spontaneous aneurysmal subarachnoid hemorrhage (aSAH) is a major cause of morbidity and mortality in the United States. The efficacy of early antiseizure medication (ASM) is debated. Recent literature reports seizure rates ranging from 7.8% to 15.2% following spontaneous aSAH. Current guidelines recommend use of early ASM in patients with "high-risk features," but whether early ASM use decreases the rate of death associated with aSAH remains unclear. This study assessed whether early administration of early ASM impacts mortality rates after spontaneous aSAH.

Methods: We conducted a retrospective cohort study using a publicly available dataset from the Massachusetts Institute of Technology, Medical Information Mart for Intensive Care-III (MIMIC) database of all patients over the age of 18 with spontaneous aSAH resulting in an intensive care unit (ICU) admission to a major United States trauma center from 2001 to 2012. The primary exposure was receiving early ASM and primary outcome of death within 7 days. Different regression models were created to explore the association between early ASM administration within 24 hours of admission and a composite outcome of seizure and/or death within 7 days of admission. Secondary outcomes included 30-day and one-year mortality.

Results: Of 253 patients with spontaneous aSAH, 148 received early ASM within 24 hours. Patients who did receive early ASM were less likely to die within 7 days of admission (adjusted odd ratio, [aOR]: 0.26 95% CI 0.10 to 0.68; P=0.006) but were more likely to have a seizure (aOR: 7.63 95% CI 2.07 to 28.17; P=0.002).

Conclusion: Early ASM administration was associated with lower rates of death and composite death/seizure within 7 days of admission among patients who presented to an ICU with spontaneous aSAH. These findings suggest broader use of early ASM in patients who present with spontaneous aSAH may improve early mortality.

背景:自发性动脉瘤性蛛网膜下腔出血(aSAH)是美国发病率和死亡率的主要原因。早期抗癫痫药物(ASM)的疗效存在争议。最近的文献报道自发性aSAH后的癫痫发作率为7.8%至15.2%。目前的指南建议在具有“高危特征”的患者中使用早期ASM,但早期ASM是否能降低与aSAH相关的死亡率尚不清楚。本研究评估早期给药是否会影响自发性aSAH后的死亡率。方法:我们使用麻省理工学院重症监护医学信息市场iii (MIMIC)数据库的公开数据集进行了一项回顾性队列研究,研究对象为2001年至2012年期间在美国一家主要创伤中心重症监护病房(ICU)住院的所有18岁以上自发性aSAH患者。主要暴露是早期ASM,主要结局是7天内死亡。建立了不同的回归模型来探讨入院24小时内早期ASM给药与入院7天内癫痫发作和/或死亡的综合结果之间的关系。次要结局包括30天和1年死亡率。结果:253例自发性aSAH患者中,148例在24小时内接受了早期ASM。接受早期ASM的患者在入院后7天内死亡的可能性较小(调整奇数比,[aOR]: 0.26 95% CI 0.10至0.68;P=0.006),但更容易发生癫痫发作(aOR: 7.63 95% CI 2.07 ~ 28.17;P = 0.002)。结论:在以自发性aSAH就诊的ICU患者中,早期使用ASM与入院后7天内较低的死亡率和复合死亡/癫痫发作率相关。这些发现表明,在自发性aSAH患者中广泛使用早期ASM可能会改善早期死亡率。
{"title":"The effect of antiseizure medication on mortality in spontaneous aneurysmal subarachnoid hemorrhage.","authors":"John Harold Kanter, Adam C Glaser, Pablo Martinez-Camblor, Jakob V E Gerstl, Anna B Lebouille-Veldman, Harshit Arora, Lauren Buhl, Myles D Boone, Christopher S Ogilvy","doi":"10.2478/jccm-2025-0014","DOIUrl":"10.2478/jccm-2025-0014","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous aneurysmal subarachnoid hemorrhage (aSAH) is a major cause of morbidity and mortality in the United States. The efficacy of early antiseizure medication (ASM) is debated. Recent literature reports seizure rates ranging from 7.8% to 15.2% following spontaneous aSAH. Current guidelines recommend use of early ASM in patients with \"high-risk features,\" but whether early ASM use decreases the rate of death associated with aSAH remains unclear. This study assessed whether early administration of early ASM impacts mortality rates after spontaneous aSAH.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using a publicly available dataset from the Massachusetts Institute of Technology, Medical Information Mart for Intensive Care-III (MIMIC) database of all patients over the age of 18 with spontaneous aSAH resulting in an intensive care unit (ICU) admission to a major United States trauma center from 2001 to 2012. The primary exposure was receiving early ASM and primary outcome of death within 7 days. Different regression models were created to explore the association between early ASM administration within 24 hours of admission and a composite outcome of seizure and/or death within 7 days of admission. Secondary outcomes included 30-day and one-year mortality.</p><p><strong>Results: </strong>Of 253 patients with spontaneous aSAH, 148 received early ASM within 24 hours. Patients who did receive early ASM were less likely to die within 7 days of admission (adjusted odd ratio, [aOR]: 0.26 95% CI 0.10 to 0.68; P=0.006) but were more likely to have a seizure (aOR: 7.63 95% CI 2.07 to 28.17; P=0.002).</p><p><strong>Conclusion: </strong>Early ASM administration was associated with lower rates of death and composite death/seizure within 7 days of admission among patients who presented to an ICU with spontaneous aSAH. These findings suggest broader use of early ASM in patients who present with spontaneous aSAH may improve early mortality.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 2","pages":"173-182"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of biomarkers testing in Emergency Department. 生物标志物检测在急诊科的应用。
IF 0.9 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-04-30 eCollection Date: 2025-04-01 DOI: 10.2478/jccm-2024-0041
Sonia Luka, Adela Golea, Raluca Mihaela Tat, Eugenia Maria Lupan Mureșan, George Teo Voicescu, Ștefan Cristian Vesa, Maria Adriana Albu, Daniela Ionescu

Introduction: In the fast-paced environment of Emergency Departments (EDs), biomarkers are essential for the rapid diagnosis and management of critical conditions.

Aim of the study: This study evaluates the current clinical practice on key biomarkers in Romanian EDs, addressing the needs of emergency medicine physicians, and the challenges associated with biomarker testing.

Material and methods: An online survey was sent to physicians working in ED to explore their perceptions, needs, and barriers regarding biomarkers, including Point-of-care (POC). Data was collected anonymously through an online platform and subsequently analyzed.

Results: This survey analyzed data from 168 completed responses, with 95.2% of respondents being specialists in emergency medicine. Procalcitonin and presepsin were most preferred for PoCT, while troponin and D-dimer were highly rated regardless of the testing method, reflecting their utility in sepsis and cardiovascular emergencies. Neuron-specific enolase, interleukin-6, and procalcitonin were the biomarkers considered needed.

Conclusions: The most frequently used biomarkers in ED were troponin, D-dimer, BNP/NT-proBNP, and procalcitonin. NSE, IL-6, and procalcitonin were the most recommended for future integration. High costs, limited availability, and false-positive concerns remain significant challenges in biomarker use.

简介:在快节奏的急诊科(EDs)环境中,生物标志物对于快速诊断和管理危重病情至关重要。研究目的:本研究评估了罗马尼亚急诊科目前对关键生物标志物的临床实践,解决了急诊医生的需求,以及与生物标志物检测相关的挑战。材料和方法:一份在线调查被发送给在急诊科工作的医生,以探讨他们对生物标志物的看法、需求和障碍,包括护理点(POC)。数据通过在线平台匿名收集,随后进行分析。结果:本调查分析了168份完整回复的数据,95.2%的受访者是急诊医学专家。降钙素原和降压素在PoCT中最受青睐,而肌钙蛋白和d -二聚体无论采用何种检测方法,都受到高度评价,这反映了它们在败血症和心血管急症中的效用。神经元特异性烯醇化酶、白细胞介素-6和降钙素原被认为是必需的生物标志物。结论:ED中最常用的生物标志物是肌钙蛋白、d -二聚体、BNP/NT-proBNP和降钙素原。NSE、IL-6和降钙素原被推荐用于未来的整合。高成本、有限的可用性和假阳性问题仍然是生物标志物使用的重大挑战。
{"title":"The use of biomarkers testing in Emergency Department.","authors":"Sonia Luka, Adela Golea, Raluca Mihaela Tat, Eugenia Maria Lupan Mureșan, George Teo Voicescu, Ștefan Cristian Vesa, Maria Adriana Albu, Daniela Ionescu","doi":"10.2478/jccm-2024-0041","DOIUrl":"10.2478/jccm-2024-0041","url":null,"abstract":"<p><strong>Introduction: </strong>In the fast-paced environment of Emergency Departments (EDs), biomarkers are essential for the rapid diagnosis and management of critical conditions.</p><p><strong>Aim of the study: </strong>This study evaluates the current clinical practice on key biomarkers in Romanian EDs, addressing the needs of emergency medicine physicians, and the challenges associated with biomarker testing.</p><p><strong>Material and methods: </strong>An online survey was sent to physicians working in ED to explore their perceptions, needs, and barriers regarding biomarkers, including Point-of-care (POC). Data was collected anonymously through an online platform and subsequently analyzed.</p><p><strong>Results: </strong>This survey analyzed data from 168 completed responses, with 95.2% of respondents being specialists in emergency medicine. Procalcitonin and presepsin were most preferred for PoCT, while troponin and D-dimer were highly rated regardless of the testing method, reflecting their utility in sepsis and cardiovascular emergencies. Neuron-specific enolase, interleukin-6, and procalcitonin were the biomarkers considered needed.</p><p><strong>Conclusions: </strong>The most frequently used biomarkers in ED were troponin, D-dimer, BNP/NT-proBNP, and procalcitonin. NSE, IL-6, and procalcitonin were the most recommended for future integration. High costs, limited availability, and false-positive concerns remain significant challenges in biomarker use.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 2","pages":"164-172"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief report on the association of preoperative hematological indices and acute deep vein thrombosis following total hip arthroplasty for osteoarthritis. 关于骨关节炎全髋关节置换术后术前血液学指标与急性深静脉血栓形成关系的简要报告。
IF 0.9 Q4 CRITICAL CARE MEDICINE Pub Date : 2025-04-30 eCollection Date: 2025-04-01 DOI: 10.2478/jccm-2025-0018
Razvan Marian Melinte, Matei Florin Negrut, Daniel Oltean-Dan, Adrian Dumitru Ivanescu, Tudor-Mihai Magdas, Oana Antal, Adela Hilda Onutu, Marian Andrei Melinte, Robert Bolcas

Introduction: Total hip arthroplasty (THA) is a standard orthopedic procedure. Deep vein thrombosis (DVT) and pulmonary embolism are potential life-threatening postoperative complications.

Aim of the study: This study aimed to assess the prognostic value of systemic inflammatory indices [monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelets-to-lymphocyte ratio (PLR), systemic inflammatory index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)] and their potential association with acute postoperative DVT.

Materials and methods: We designed a multicentric, retrospective, observational cohort study, including adult patients undergoing elective HTA. Patients were divided into two groups, the DVT and non-DVT groups. We investigated the development of acute DVT early, and at 4 weeks after surgery and also registered length of hospital stay and mortality. All demographic data and laboratory data, hematological indices were extracted from patients files.

Results: 199 patients were included. Of those, 12 (6.03%) developed DVT and 187 (93.97%) did not. There was no statistically significant difference between patient age, gender, BMI, smoking status or comorbidities. No difference was founds between the two groups regarding median values of MLR (0.31 vs 0.27, p=0.12), NLR (3.16 vs 2.42, p=0.27), PLR (163.39 vs 123.01, p=0.27), SII (660.26 vs 568.52, p=0.33), SIRI (67.5 vs 65.26, p=0.89) and AISI (302.35 vs 290.48, p=0.85). Length of hospital stay was not significantly different (median 9 days in the DVT group vs 7 days in the non-DVT group, p=0.38), but mortality was significantly higher in the DVT group (3 deaths vs none in the non-DVT group, p<0.001).

Conclusion: MLR, NLR, PRL, SII, SIRI and AISI were not associated with the development of acute DVT following HTA in our study population.

全髋关节置换术(THA)是一种标准的骨科手术。深静脉血栓和肺栓塞是潜在的危及生命的术后并发症。研究目的:本研究旨在评估全身炎症指数[单核细胞与淋巴细胞比值(MLR)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、全身炎症指数(SII)、全身炎症反应指数(SIRI)和全身炎症总指数(AISI)]的预后价值及其与急性术后DVT的潜在关联。材料和方法:我们设计了一项多中心、回顾性、观察性队列研究,包括接受选择性HTA治疗的成年患者。患者分为深静脉血栓形成组和非深静脉血栓形成组。我们调查了急性深静脉血栓的早期和术后4周的发展情况,并记录了住院时间和死亡率。所有人口统计资料、实验室数据、血液学指标均从患者档案中提取。结果:纳入199例患者。其中12例(6.03%)发生DVT, 187例(93.97%)未发生DVT。患者年龄、性别、BMI、吸烟状况或合并症之间无统计学差异。两组间MLR (0.31 vs 0.27, p=0.12)、NLR (3.16 vs 2.42, p=0.27)、PLR (163.39 vs 123.01, p=0.27)、SII (660.26 vs 568.52, p=0.33)、SIRI (67.5 vs 65.26, p=0.89)和AISI (302.35 vs 290.48, p=0.85)的中位数均无差异。住院时间无显著差异(DVT组中位数为9天,非DVT组中位数为7天,p=0.38),但DVT组的死亡率显著高于DVT组(3例死亡,非DVT组无死亡,p结论:在我们的研究人群中,MLR、NLR、PRL、SII、SIRI和AISI与HTA后急性DVT的发生无关。
{"title":"A brief report on the association of preoperative hematological indices and acute deep vein thrombosis following total hip arthroplasty for osteoarthritis.","authors":"Razvan Marian Melinte, Matei Florin Negrut, Daniel Oltean-Dan, Adrian Dumitru Ivanescu, Tudor-Mihai Magdas, Oana Antal, Adela Hilda Onutu, Marian Andrei Melinte, Robert Bolcas","doi":"10.2478/jccm-2025-0018","DOIUrl":"10.2478/jccm-2025-0018","url":null,"abstract":"<p><strong>Introduction: </strong>Total hip arthroplasty (THA) is a standard orthopedic procedure. Deep vein thrombosis (DVT) and pulmonary embolism are potential life-threatening postoperative complications.</p><p><strong>Aim of the study: </strong>This study aimed to assess the prognostic value of systemic inflammatory indices [monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelets-to-lymphocyte ratio (PLR), systemic inflammatory index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)] and their potential association with acute postoperative DVT.</p><p><strong>Materials and methods: </strong>We designed a multicentric, retrospective, observational cohort study, including adult patients undergoing elective HTA. Patients were divided into two groups, the DVT and non-DVT groups. We investigated the development of acute DVT early, and at 4 weeks after surgery and also registered length of hospital stay and mortality. All demographic data and laboratory data, hematological indices were extracted from patients files.</p><p><strong>Results: </strong>199 patients were included. Of those, 12 (6.03%) developed DVT and 187 (93.97%) did not. There was no statistically significant difference between patient age, gender, BMI, smoking status or comorbidities. No difference was founds between the two groups regarding median values of MLR (0.31 vs 0.27, p=0.12), NLR (3.16 vs 2.42, p=0.27), PLR (163.39 vs 123.01, p=0.27), SII (660.26 vs 568.52, p=0.33), SIRI (67.5 vs 65.26, p=0.89) and AISI (302.35 vs 290.48, p=0.85). Length of hospital stay was not significantly different (median 9 days in the DVT group vs 7 days in the non-DVT group, p=0.38), but mortality was significantly higher in the DVT group (3 deaths vs none in the non-DVT group, p<0.001).</p><p><strong>Conclusion: </strong>MLR, NLR, PRL, SII, SIRI and AISI were not associated with the development of acute DVT following HTA in our study population.</p>","PeriodicalId":44227,"journal":{"name":"Journal of Critical Care Medicine","volume":"11 2","pages":"192-197"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1